NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $73.65 +1.65 (+2.29%) As of 03:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Solventum Stock (NYSE:SOLV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Solventum alerts:Sign Up Key Stats Today's Range$72.01▼$74.1750-Day Range$70.87▼$78.2152-Week Range$59.35▼$85.92Volume582,805 shsAverage Volume1.08 million shsMarket Capitalization$12.77 billionP/E Ratio34.08Dividend YieldN/APrice Target$85.75Consensus RatingHold Company Overview Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota. Read More Solventum Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks35th Percentile Overall ScoreSOLV MarketRank™: Solventum scored higher than 35% of companies evaluated by MarketBeat, and ranked 756th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingSolventum has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 4 buy ratings, 6 hold ratings, and 1 sell rating.Amount of Analyst CoverageSolventum has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-16.57% Earnings GrowthEarnings for Solventum are expected to decrease by -16.57% in the coming year, from $6.58 to $5.49 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Solventum is 34.16, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.38.Price to Earnings Ratio vs. SectorThe P/E ratio of Solventum is 34.16, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 30.90.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.77. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSolventum has a P/B Ratio of 3.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Solventum's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.72% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Solventum has recently decreased by 2.08%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.72% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Solventum has recently decreased by 2.08%, indicating that investor sentiment is improving. News and Social Media2.8 / 5News Sentiment1.13 News SentimentSolventum has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 22 news articles for Solventum this week, compared to 13 articles on an average week.Search InterestOnly 5 people have searched for SOLV on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.05% of the stock of Solventum is held by insiders.Read more about Solventum's insider trading history. Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Email Address SOLV Stock News HeadlinesInsider Selling: Solventum Corporation (NYSE:SOLV) Major Shareholder Sells 8,800,000 Shares of StockAugust 19 at 4:11 AM | insidertrades.comSolventum Corporation (SOLV) Announces $1.75 Billion Cash Tender Offers5 hours ago | gurufocus.com"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That's why we've rushed to update our book "Crypto Revolution" – to show you exactly how to position yourself for this historic opportunity.August 22 at 2:00 AM | Crypto 101 Media (Ad)Solventum Corporation Initiates $1.75 Billion Tender OffersAugust 22 at 8:50 AM | tipranks.comSolventum Announces $1.75 Billion Note Tender OffersAugust 22 at 8:19 AM | prnewswire.comSurgical Equipment & Consumables - Diversified Stocks Q2 Teardown: Solventum (NYSE:SOLV) Vs The RestAugust 21 at 7:26 AM | finance.yahoo.comDo Wall Street Analysts Like Solventum Stock?August 19 at 3:38 AM | msn.comSolventum (NYSE:SOLV) Upgraded by Wall Street Zen to Strong-Buy RatingAugust 17, 2025 | americanbankingnews.comSee More Headlines SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $66.06 at the beginning of the year. Since then, SOLV stock has increased by 11.7% and is now trading at $73.8050. How were Solventum's earnings last quarter? Solventum Corporation (NYSE:SOLV) posted its quarterly earnings results on Thursday, August, 7th. The company reported $1.69 earnings per share for the quarter, topping the consensus estimate of $1.45 by $0.24. Solventum's quarterly revenue was up 3.8% on a year-over-year basis. Read the conference call transcript. Who are Solventum's major shareholders? Top institutional investors of Solventum include Vanguard Group Inc. (9.39%), Independent Franchise Partners LLP (5.85%), State Street Corp (3.52%) and Davis Selected Advisers (3.17%). How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Solventum own? Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AU Optronics (AUOTY). Company Calendar Last Earnings8/07/2025Today8/22/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNYSE:SOLV Previous SymbolNYSE:SOLV CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees22,000Year FoundedN/APrice Target and Rating Average Price Target for Solventum$85.75 High Price Target$103.00 Low Price Target$71.00 Potential Upside/Downside+19.3%Consensus RatingHold Rating Score (0-4)2.27 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$2.16 Trailing P/E Ratio33.29 Forward P/E Ratio10.93 P/E Growth1.77Net Income$478 million Net Margins4.52% Pretax Margin3.83% Return on Equity29.93% Return on Assets6.65% Debt Debt-to-Equity Ratio2.14 Current Ratio1.22 Quick Ratio0.86 Sales & Book Value Annual Sales$8.25 billion Price / Sales1.51 Cash Flow$9.81 per share Price / Cash Flow7.33 Book Value$21.02 per share Price / Book3.42Miscellaneous Outstanding Shares173,390,000Free Float173,301,000Market Cap$12.47 billion OptionableOptionable Beta0.52 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:SOLV) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.